Europe Cancer Immunotherapy Market (2018 - 2024)
The Europe Cancer Immunotherapy Market would witness market growth of 13.5 % CAGR during the forecast period (2018 – 2024). Cancer immunotherapy is the type of cancer treatment helping the immune system fight cancer. There are various kinds of cancer immunotherapies used and they are monoclonal antibody, therapeutic cancer vaccines, checkpoint inhibitors, cytokines, and others. Growing patient population that is suffering from different types of cancer such as lung cancer, breast cancer, ovarian cancer, and other cancers are the factors that drive the global cancer immunotherapy market. Additionally, growing geriatric population and governmental contribution to healthcare expenditure are some other factors that add to the market growth.
Based on technology, the market is segmented into Monoclonal Antibodies, Cytokines & Immunomodulators and other technology. Based on application, the market is segmented into Lung cancer, Breast cancer, Colorectal, Prostate cancer, Head & Neck cancer and other application. Based on end user the market is segmented into Hospitals, Clinics and other end user. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include AstraZeneca, Amgen Inc., Eli Lilly and Company, Merck & Co., Inc., Bristol-Myers Squibb Company, Pfizer Inc., Bayer Ag, Immunomedics Inc., Novartis AG, F. Hoffmann-La Roche Ltd
Based on technology, the market is segmented into Monoclonal Antibodies, Cytokines & Immunomodulators and other technology. Based on application, the market is segmented into Lung cancer, Breast cancer, Colorectal, Prostate cancer, Head & Neck cancer and other application. Based on end user the market is segmented into Hospitals, Clinics and other end user. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include AstraZeneca, Amgen Inc., Eli Lilly and Company, Merck & Co., Inc., Bristol-Myers Squibb Company, Pfizer Inc., Bayer Ag, Immunomedics Inc., Novartis AG, F. Hoffmann-La Roche Ltd
CHAPTER 1. MARKET SCOPE & METHODOLOGY
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Cancer Immunotherapy Market, by Technology
1.4.2 Europe Cancer Immunotherapy Market, by Application
1.4.3 Europe Cancer Immunotherapy Market, by End User
1.4.4 Europe Cancer Immunotherapy Market, by Countries
1.5 Methodology for the research
CHAPTER 2. MARKET OVERVIEW
2.1 Introduction
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
CHAPTER 3. EUROPE CANCER IMMUNOTHERAPY MARKET BY TECHNOLOGY
3.1.1 Europe Monoclonal Antibodies Cancer Immunotherapy Market by Country
3.1.2 Europe Cytokines & Immunomodulators Cancer Immunotherapy Market by Country
3.1.3 Europe Other Technology Cancer Immunotherapy Market by Country
CHAPTER 4. EUROPE CANCER IMMUNOTHERAPY MARKET BY APPLICATION
4.1.1 Europe Cancer Immunotherapy Lung Cancer Market by Country
4.1.2 Europe Cancer Immunotherapy Breast Cancer Market by Country
4.1.3 Europe Cancer Immunotherapy Colorectal Cancer Market by Country
4.1.4 Europe Cancer Immunotherapy Melanoma Market by Country
4.1.5 Europe Cancer Immunotherapy Prostate Cancer Market by Country
4.1.6 Europe Cancer Immunotherapy Head & Neck Cancer Market by Country
4.1.7 Europe Other Application Cancer Immunotherapy Market by Country
CHAPTER 5. EUROPE CANCER IMMUNOTHERAPY MARKET BY END USER
5.1.1 Europe Hospitals Cancer Immunotherapy Market by Country
5.1.2 Europe Clinics Cancer Immunotherapy Market by Country
5.1.3 Europe Other End User Cancer Immunotherapy Market by Country
CHAPTER 6. EUROPE CANCER IMMUNOTHERAPY MARKET BY COUNTRY
6.1 Germany Cancer Immunotherapy Market
6.1.1 Germany Cancer Immunotherapy Market by Technology
6.1.2 Germany Cancer Immunotherapy Market by Application
6.1.3 Germany Cancer Immunotherapy Market by End User
6.2 UK Cancer Immunotherapy Market
6.2.1 UK Cancer Immunotherapy Market by Technology
6.2.2 UK Cancer Immunotherapy Market by Application
6.2.3 UK Cancer Immunotherapy Market by End User
6.3 France Cancer Immunotherapy Market
6.3.1 France Cancer Immunotherapy Market by Technology
6.3.2 France Cancer Immunotherapy Market by Application
6.3.3 France Cancer Immunotherapy Market by End User
6.4 Russia Cancer Immunotherapy Market
6.4.1 Russia Cancer Immunotherapy Market by Technology
6.4.2 Russia Cancer Immunotherapy Market by Application
6.4.3 Russia Cancer Immunotherapy Market by End User
6.5 Spain Cancer Immunotherapy Market
6.5.1 Spain Cancer Immunotherapy Market by Technology
6.5.2 Spain Cancer Immunotherapy Market by Application
6.5.3 Spain Cancer Immunotherapy Market by End User
6.6 Italy Cancer Immunotherapy Market
6.6.1 Italy Cancer Immunotherapy Market by Technology
6.6.2 Italy Cancer Immunotherapy Market by Application
6.6.3 Italy Cancer Immunotherapy Market by End User
6.7 Rest of Europe Cancer Immunotherapy Market
6.7.1 Rest of Europe Cancer Immunotherapy Market by Technology
6.7.2 Rest of Europe Cancer Immunotherapy Market by Application
6.7.3 Rest of Europe Cancer Immunotherapy Market by End User
CHAPTER 7. COMPANY PROFILES
7.1 Amgen Inc.
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental & Regional Analysis
7.1.4 Research and Development Expense
7.2 Merck & Company, Inc.
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Regional and Segmental Analysis
7.2.4 Research & Development
7.3 Pfizer Inc.
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Segmental &Regional Analysis
7.3.4 Revenue analysis by Region
7.3.5 Research and Development
7.4 Immunomedics Inc.
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Revenue Analysis by Region
7.4.4 Research and Development
7.5 Astrazeneca Plc.
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Segmental analysis
7.5.4 Research & Development
7.6 F. Hoffmann-La Roche Ltd.
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Revenue & Segment analysis
7.6.4 Research and Development
7.7 Eli Lilly and Company
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Segmental and Regional Analysis
7.7.4 Research & Development Expense
7.8 Novartis AG
7.8.1 Company Overview
7.8.2 Financial Analysis
7.8.3 Segmental and Regional Analysis
7.8.4 Research & Development Expense
7.9 Bristol-Myers Squibb Company
7.9.1 Company Overview
7.1 Bayer AG
7.10.1 Company Overview
7.10.2 Financial Analysis
7.10.3 Segmental and Regional Analysis
7.10.4 Research & Development Expense
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Cancer Immunotherapy Market, by Technology
1.4.2 Europe Cancer Immunotherapy Market, by Application
1.4.3 Europe Cancer Immunotherapy Market, by End User
1.4.4 Europe Cancer Immunotherapy Market, by Countries
1.5 Methodology for the research
CHAPTER 2. MARKET OVERVIEW
2.1 Introduction
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
CHAPTER 3. EUROPE CANCER IMMUNOTHERAPY MARKET BY TECHNOLOGY
3.1.1 Europe Monoclonal Antibodies Cancer Immunotherapy Market by Country
3.1.2 Europe Cytokines & Immunomodulators Cancer Immunotherapy Market by Country
3.1.3 Europe Other Technology Cancer Immunotherapy Market by Country
CHAPTER 4. EUROPE CANCER IMMUNOTHERAPY MARKET BY APPLICATION
4.1.1 Europe Cancer Immunotherapy Lung Cancer Market by Country
4.1.2 Europe Cancer Immunotherapy Breast Cancer Market by Country
4.1.3 Europe Cancer Immunotherapy Colorectal Cancer Market by Country
4.1.4 Europe Cancer Immunotherapy Melanoma Market by Country
4.1.5 Europe Cancer Immunotherapy Prostate Cancer Market by Country
4.1.6 Europe Cancer Immunotherapy Head & Neck Cancer Market by Country
4.1.7 Europe Other Application Cancer Immunotherapy Market by Country
CHAPTER 5. EUROPE CANCER IMMUNOTHERAPY MARKET BY END USER
5.1.1 Europe Hospitals Cancer Immunotherapy Market by Country
5.1.2 Europe Clinics Cancer Immunotherapy Market by Country
5.1.3 Europe Other End User Cancer Immunotherapy Market by Country
CHAPTER 6. EUROPE CANCER IMMUNOTHERAPY MARKET BY COUNTRY
6.1 Germany Cancer Immunotherapy Market
6.1.1 Germany Cancer Immunotherapy Market by Technology
6.1.2 Germany Cancer Immunotherapy Market by Application
6.1.3 Germany Cancer Immunotherapy Market by End User
6.2 UK Cancer Immunotherapy Market
6.2.1 UK Cancer Immunotherapy Market by Technology
6.2.2 UK Cancer Immunotherapy Market by Application
6.2.3 UK Cancer Immunotherapy Market by End User
6.3 France Cancer Immunotherapy Market
6.3.1 France Cancer Immunotherapy Market by Technology
6.3.2 France Cancer Immunotherapy Market by Application
6.3.3 France Cancer Immunotherapy Market by End User
6.4 Russia Cancer Immunotherapy Market
6.4.1 Russia Cancer Immunotherapy Market by Technology
6.4.2 Russia Cancer Immunotherapy Market by Application
6.4.3 Russia Cancer Immunotherapy Market by End User
6.5 Spain Cancer Immunotherapy Market
6.5.1 Spain Cancer Immunotherapy Market by Technology
6.5.2 Spain Cancer Immunotherapy Market by Application
6.5.3 Spain Cancer Immunotherapy Market by End User
6.6 Italy Cancer Immunotherapy Market
6.6.1 Italy Cancer Immunotherapy Market by Technology
6.6.2 Italy Cancer Immunotherapy Market by Application
6.6.3 Italy Cancer Immunotherapy Market by End User
6.7 Rest of Europe Cancer Immunotherapy Market
6.7.1 Rest of Europe Cancer Immunotherapy Market by Technology
6.7.2 Rest of Europe Cancer Immunotherapy Market by Application
6.7.3 Rest of Europe Cancer Immunotherapy Market by End User
CHAPTER 7. COMPANY PROFILES
7.1 Amgen Inc.
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental & Regional Analysis
7.1.4 Research and Development Expense
7.2 Merck & Company, Inc.
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Regional and Segmental Analysis
7.2.4 Research & Development
7.3 Pfizer Inc.
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Segmental &Regional Analysis
7.3.4 Revenue analysis by Region
7.3.5 Research and Development
7.4 Immunomedics Inc.
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Revenue Analysis by Region
7.4.4 Research and Development
7.5 Astrazeneca Plc.
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Segmental analysis
7.5.4 Research & Development
7.6 F. Hoffmann-La Roche Ltd.
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Revenue & Segment analysis
7.6.4 Research and Development
7.7 Eli Lilly and Company
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Segmental and Regional Analysis
7.7.4 Research & Development Expense
7.8 Novartis AG
7.8.1 Company Overview
7.8.2 Financial Analysis
7.8.3 Segmental and Regional Analysis
7.8.4 Research & Development Expense
7.9 Bristol-Myers Squibb Company
7.9.1 Company Overview
7.1 Bayer AG
7.10.1 Company Overview
7.10.2 Financial Analysis
7.10.3 Segmental and Regional Analysis
7.10.4 Research & Development Expense
LIST OF TABLES
TABLE 1 EUROPE CANCER IMMUNOTHERAPY MARKET, 2014 - 2017, USD MILLION
TABLE 2 EUROPE CANCER IMMUNOTHERAPY MARKET, 2018 - 2024, USD MILLION
TABLE 3 EUROPE CANCER IMMUNOTHERAPY MARKET BY TECHNOLOGY, 2014 - 2017, USD MILLION
TABLE 4 EUROPE CANCER IMMUNOTHERAPY MARKET BY TECHNOLOGY, 2018 - 2024, USD MILLION
TABLE 5 EUROPE MONOCLONAL ANTIBODIES CANCER IMMUNOTHERAPY MARKET BY COUNTRY, 2014 - 2017, USD MILLION
TABLE 6 EUROPE MONOCLONAL ANTIBODIES CANCER IMMUNOTHERAPY MARKET BY COUNTRY, 2018 - 2024, USD MILLION
TABLE 7 EUROPE CYTOKINES & IMMUNOMODULATORS CANCER IMMUNOTHERAPY MARKET BY COUNTRY, 2014 - 2017, USD MILLION
TABLE 8 EUROPE CYTOKINES & IMMUNOMODULATORS CANCER IMMUNOTHERAPY MARKET BY COUNTRY, 2018 - 2024, USD MILLION
TABLE 9 EUROPE OTHER TECHNOLOGY CANCER IMMUNOTHERAPY MARKET BY COUNTRY, 2014 - 2017, USD MILLION
TABLE 10 EUROPE OTHER TECHNOLOGY CANCER IMMUNOTHERAPY MARKET BY COUNTRY, 2018 - 2024, USD MILLION
TABLE 11 EUROPE CANCER IMMUNOTHERAPY MARKET BY APPLICATION, 2014 - 2017, USD MILLION
TABLE 12 EUROPE CANCER IMMUNOTHERAPY MARKET BY APPLICATION, 2018 - 2024, USD MILLION
TABLE 13 EUROPE CANCER IMMUNOTHERAPY LUNG CANCER MARKET BY COUNTRY, 2014 - 2017, USD MILLION
TABLE 14 EUROPE CANCER IMMUNOTHERAPY LUNG CANCER MARKET BY COUNTRY, 2018 - 2024, USD MILLION
TABLE 15 EUROPE CANCER IMMUNOTHERAPY BREAST CANCER MARKET BY COUNTRY, 2014 - 2017, USD MILLION
TABLE 16 EUROPE CANCER IMMUNOTHERAPY BREAST CANCER MARKET BY COUNTRY, 2018 - 2024, USD MILLION
TABLE 17 EUROPE CANCER IMMUNOTHERAPY COLORECTAL CANCER MARKET BY COUNTRY, 2014 - 2017, USD MILLION
TABLE 18 EUROPE CANCER IMMUNOTHERAPY COLORECTAL CANCER MARKET BY COUNTRY, 2018 - 2024, USD MILLION
TABLE 19 EUROPE CANCER IMMUNOTHERAPY MELANOMA MARKET BY COUNTRY, 2014 - 2017, USD MILLION
TABLE 20 EUROPE CANCER IMMUNOTHERAPY MELANOMA MARKET BY COUNTRY, 2018 - 2024, USD MILLION
TABLE 21 EUROPE CANCER IMMUNOTHERAPY PROSTATE CANCER MARKET BY COUNTRY, 2014 - 2017, USD MILLION
TABLE 22 EUROPE CANCER IMMUNOTHERAPY PROSTATE CANCER MARKET BY COUNTRY, 2018 - 2024, USD MILLION
TABLE 23 EUROPE CANCER IMMUNOTHERAPY HEAD & NECK CANCER MARKET BY COUNTRY, 2014 - 2017, USD MILLION
TABLE 24 EUROPE CANCER IMMUNOTHERAPY HEAD & NECK CANCER MARKET BY COUNTRY, 2018 - 2024, USD MILLION
TABLE 25 EUROPE OTHER APPLICATION CANCER IMMUNOTHERAPY MARKET BY COUNTRY, 2014 - 2017, USD MILLION
TABLE 26 EUROPE OTHER APPLICATION CANCER IMMUNOTHERAPY MARKET BY COUNTRY, 2018 - 2024, USD MILLION
TABLE 27 EUROPE CANCER IMMUNOTHERAPY MARKET BY END USER, 2014 - 2017, USD MILLION
TABLE 28 EUROPE CANCER IMMUNOTHERAPY MARKET BY END USER, 2018 - 2024, USD MILLION
TABLE 29 EUROPE HOSPITALS CANCER IMMUNOTHERAPY MARKET BY COUNTRY, 2014 - 2017, USD MILLION
TABLE 30 EUROPE HOSPITALS CANCER IMMUNOTHERAPY MARKET BY COUNTRY, 2018 - 2024, USD MILLION
TABLE 31 EUROPE CLINICS CANCER IMMUNOTHERAPY MARKET BY COUNTRY, 2014 - 2017, USD MILLION
TABLE 32 EUROPE CLINICS CANCER IMMUNOTHERAPY MARKET BY COUNTRY, 2018 - 2024, USD MILLION
TABLE 33 EUROPE OTHER END USER CANCER IMMUNOTHERAPY MARKET BY COUNTRY, 2014 - 2017, USD MILLION
TABLE 34 EUROPE OTHER END USER CANCER IMMUNOTHERAPY MARKET BY COUNTRY, 2018 - 2024, USD MILLION
TABLE 35 EUROPE CANCER IMMUNOTHERAPY MARKET BY COUNTRY, 2014 - 2017, USD MILLION
TABLE 36 EUROPE CANCER IMMUNOTHERAPY MARKET BY COUNTRY, 2018 - 2024, USD MILLION
TABLE 37 GERMANY CANCER IMMUNOTHERAPY MARKET, 2014 - 2017, USD MILLION
TABLE 38 GERMANY CANCER IMMUNOTHERAPY MARKET, 2018 - 2024, USD MILLION
TABLE 39 GERMANY CANCER IMMUNOTHERAPY MARKET BY TECHNOLOGY, 2014 - 2017, USD MILLION
TABLE 40 GERMANY CANCER IMMUNOTHERAPY MARKET BY TECHNOLOGY, 2018 - 2024, USD MILLION
TABLE 41 GERMANY CANCER IMMUNOTHERAPY MARKET BY APPLICATION, 2014 - 2017, USD MILLION
TABLE 42 GERMANY CANCER IMMUNOTHERAPY MARKET BY APPLICATION, 2018 - 2024, USD MILLION
TABLE 43 GERMANY CANCER IMMUNOTHERAPY MARKET BY END USER, 2014 - 2017, USD MILLION
TABLE 44 GERMANY CANCER IMMUNOTHERAPY MARKET BY END USER, 2018 - 2024, USD MILLION
TABLE 45 UK CANCER IMMUNOTHERAPY MARKET, 2014 - 2017, USD MILLION
TABLE 46 UK CANCER IMMUNOTHERAPY MARKET, 2018 - 2024, USD MILLION
TABLE 47 UK CANCER IMMUNOTHERAPY MARKET BY TECHNOLOGY, 2014 - 2017, USD MILLION
TABLE 48 UK CANCER IMMUNOTHERAPY MARKET BY TECHNOLOGY, 2018 - 2024, USD MILLION
TABLE 49 UK CANCER IMMUNOTHERAPY MARKET BY APPLICATION, 2014 - 2017, USD MILLION
TABLE 50 UK CANCER IMMUNOTHERAPY MARKET BY APPLICATION, 2018 - 2024, USD MILLION
TABLE 51 UK CANCER IMMUNOTHERAPY MARKET BY END USER, 2014 - 2017, USD MILLION
TABLE 52 UK CANCER IMMUNOTHERAPY MARKET BY END USER, 2018 - 2024, USD MILLION
TABLE 53 FRANCE CANCER IMMUNOTHERAPY MARKET, 2014 - 2017, USD MILLION
TABLE 54 FRANCE CANCER IMMUNOTHERAPY MARKET, 2018 - 2024, USD MILLION
TABLE 55 FRANCE CANCER IMMUNOTHERAPY MARKET BY TECHNOLOGY, 2014 - 2017, USD MILLION
TABLE 56 FRANCE CANCER IMMUNOTHERAPY MARKET BY TECHNOLOGY, 2018 - 2024, USD MILLION
TABLE 57 FRANCE CANCER IMMUNOTHERAPY MARKET BY APPLICATION, 2014 - 2017, USD MILLION
TABLE 58 FRANCE CANCER IMMUNOTHERAPY MARKET BY APPLICATION, 2018 - 2024, USD MILLION
TABLE 59 FRANCE CANCER IMMUNOTHERAPY MARKET BY END USER, 2014 - 2017, USD MILLION
TABLE 60 FRANCE CANCER IMMUNOTHERAPY MARKET BY END USER, 2018 - 2024, USD MILLION
TABLE 61 RUSSIA CANCER IMMUNOTHERAPY MARKET, 2014 - 2017, USD MILLION
TABLE 62 RUSSIA CANCER IMMUNOTHERAPY MARKET, 2018 - 2024, USD MILLION
TABLE 63 RUSSIA CANCER IMMUNOTHERAPY MARKET BY TECHNOLOGY, 2014 - 2017, USD MILLION
TABLE 64 RUSSIA CANCER IMMUNOTHERAPY MARKET BY TECHNOLOGY, 2018 - 2024, USD MILLION
TABLE 65 RUSSIA CANCER IMMUNOTHERAPY MARKET BY APPLICATION, 2014 - 2017, USD MILLION
TABLE 66 RUSSIA CANCER IMMUNOTHERAPY MARKET BY APPLICATION, 2018 - 2024, USD MILLION
TABLE 67 RUSSIA CANCER IMMUNOTHERAPY MARKET BY END USER, 2014 - 2017, USD MILLION
TABLE 68 RUSSIA CANCER IMMUNOTHERAPY MARKET BY END USER, 2018 - 2024, USD MILLION
TABLE 69 SPAIN CANCER IMMUNOTHERAPY MARKET, 2014 - 2017, USD MILLION
TABLE 70 SPAIN CANCER IMMUNOTHERAPY MARKET, 2018 - 2024, USD MILLION
TABLE 71 SPAIN CANCER IMMUNOTHERAPY MARKET BY TECHNOLOGY, 2014 - 2017, USD MILLION
TABLE 72 SPAIN CANCER IMMUNOTHERAPY MARKET BY TECHNOLOGY, 2018 - 2024, USD MILLION
TABLE 73 SPAIN CANCER IMMUNOTHERAPY MARKET BY APPLICATION, 2014 - 2017, USD MILLION
TABLE 74 SPAIN CANCER IMMUNOTHERAPY MARKET BY APPLICATION, 2018 - 2024, USD MILLION
TABLE 75 SPAIN CANCER IMMUNOTHERAPY MARKET BY END USER, 2014 - 2017, USD MILLION
TABLE 76 SPAIN CANCER IMMUNOTHERAPY MARKET BY END USER, 2018 - 2024, USD MILLION
TABLE 77 ITALY CANCER IMMUNOTHERAPY MARKET, 2014 - 2017, USD MILLION
TABLE 78 ITALY CANCER IMMUNOTHERAPY MARKET, 2018 - 2024, USD MILLION
TABLE 79 ITALY CANCER IMMUNOTHERAPY MARKET BY TECHNOLOGY, 2014 - 2017, USD MILLION
TABLE 80 ITALY CANCER IMMUNOTHERAPY MARKET BY TECHNOLOGY, 2018 - 2024, USD MILLION
TABLE 81 ITALY CANCER IMMUNOTHERAPY MARKET BY APPLICATION, 2014 - 2017, USD MILLION
TABLE 82 ITALY CANCER IMMUNOTHERAPY MARKET BY APPLICATION, 2018 - 2024, USD MILLION
TABLE 83 ITALY CANCER IMMUNOTHERAPY MARKET BY END USER, 2014 - 2017, USD MILLION
TABLE 84 ITALY CANCER IMMUNOTHERAPY MARKET BY END USER, 2018 - 2024, USD MILLION
TABLE 85 REST OF EUROPE CANCER IMMUNOTHERAPY MARKET, 2014 - 2017, USD MILLION
TABLE 86 REST OF EUROPE CANCER IMMUNOTHERAPY MARKET, 2018 - 2024, USD MILLION
TABLE 87 REST OF EUROPE CANCER IMMUNOTHERAPY MARKET BY TECHNOLOGY, 2014 - 2017, USD MILLION
TABLE 88 REST OF EUROPE CANCER IMMUNOTHERAPY MARKET BY TECHNOLOGY, 2018 - 2024, USD MILLION
TABLE 89 REST OF EUROPE CANCER IMMUNOTHERAPY MARKET BY APPLICATION, 2014 - 2017, USD MILLION
TABLE 90 REST OF EUROPE CANCER IMMUNOTHERAPY MARKET BY APPLICATION, 2018 - 2024, USD MILLION
TABLE 91 REST OF EUROPE CANCER IMMUNOTHERAPY MARKET BY END USER, 2014 - 2017, USD MILLION
TABLE 92 REST OF EUROPE CANCER IMMUNOTHERAPY MARKET BY END USER, 2018 - 2024, USD MILLION
TABLE 93 KEY INFORMATION-AMGEN INC.
TABLE 94 KEY INFORMATION-MERCK & COMPANY INC.
TABLE 95 KEY INFORMATION- PFIZER INC.
TABLE 96 KEY INFORMATION- IMMUNOMEDICS INC.
TABLE 97 KEY INFORMATION- ASTRAZENECA PLC.
TABLE 98 KEY INFORMATION- F. HOFFMANN-LA ROCHE LTD.
TABLE 99 KEY INFORMATION – ELI LILLY AND COMPANY
TABLE 100 KEY INFORMATION – NOVARTIS AG
TABLE 101 KEY INFORMATION - BRISTOL-MYERS SQUIBB COMPANY
TABLE 102 KEY INFORMATION – BAYER AG
TABLE 1 EUROPE CANCER IMMUNOTHERAPY MARKET, 2014 - 2017, USD MILLION
TABLE 2 EUROPE CANCER IMMUNOTHERAPY MARKET, 2018 - 2024, USD MILLION
TABLE 3 EUROPE CANCER IMMUNOTHERAPY MARKET BY TECHNOLOGY, 2014 - 2017, USD MILLION
TABLE 4 EUROPE CANCER IMMUNOTHERAPY MARKET BY TECHNOLOGY, 2018 - 2024, USD MILLION
TABLE 5 EUROPE MONOCLONAL ANTIBODIES CANCER IMMUNOTHERAPY MARKET BY COUNTRY, 2014 - 2017, USD MILLION
TABLE 6 EUROPE MONOCLONAL ANTIBODIES CANCER IMMUNOTHERAPY MARKET BY COUNTRY, 2018 - 2024, USD MILLION
TABLE 7 EUROPE CYTOKINES & IMMUNOMODULATORS CANCER IMMUNOTHERAPY MARKET BY COUNTRY, 2014 - 2017, USD MILLION
TABLE 8 EUROPE CYTOKINES & IMMUNOMODULATORS CANCER IMMUNOTHERAPY MARKET BY COUNTRY, 2018 - 2024, USD MILLION
TABLE 9 EUROPE OTHER TECHNOLOGY CANCER IMMUNOTHERAPY MARKET BY COUNTRY, 2014 - 2017, USD MILLION
TABLE 10 EUROPE OTHER TECHNOLOGY CANCER IMMUNOTHERAPY MARKET BY COUNTRY, 2018 - 2024, USD MILLION
TABLE 11 EUROPE CANCER IMMUNOTHERAPY MARKET BY APPLICATION, 2014 - 2017, USD MILLION
TABLE 12 EUROPE CANCER IMMUNOTHERAPY MARKET BY APPLICATION, 2018 - 2024, USD MILLION
TABLE 13 EUROPE CANCER IMMUNOTHERAPY LUNG CANCER MARKET BY COUNTRY, 2014 - 2017, USD MILLION
TABLE 14 EUROPE CANCER IMMUNOTHERAPY LUNG CANCER MARKET BY COUNTRY, 2018 - 2024, USD MILLION
TABLE 15 EUROPE CANCER IMMUNOTHERAPY BREAST CANCER MARKET BY COUNTRY, 2014 - 2017, USD MILLION
TABLE 16 EUROPE CANCER IMMUNOTHERAPY BREAST CANCER MARKET BY COUNTRY, 2018 - 2024, USD MILLION
TABLE 17 EUROPE CANCER IMMUNOTHERAPY COLORECTAL CANCER MARKET BY COUNTRY, 2014 - 2017, USD MILLION
TABLE 18 EUROPE CANCER IMMUNOTHERAPY COLORECTAL CANCER MARKET BY COUNTRY, 2018 - 2024, USD MILLION
TABLE 19 EUROPE CANCER IMMUNOTHERAPY MELANOMA MARKET BY COUNTRY, 2014 - 2017, USD MILLION
TABLE 20 EUROPE CANCER IMMUNOTHERAPY MELANOMA MARKET BY COUNTRY, 2018 - 2024, USD MILLION
TABLE 21 EUROPE CANCER IMMUNOTHERAPY PROSTATE CANCER MARKET BY COUNTRY, 2014 - 2017, USD MILLION
TABLE 22 EUROPE CANCER IMMUNOTHERAPY PROSTATE CANCER MARKET BY COUNTRY, 2018 - 2024, USD MILLION
TABLE 23 EUROPE CANCER IMMUNOTHERAPY HEAD & NECK CANCER MARKET BY COUNTRY, 2014 - 2017, USD MILLION
TABLE 24 EUROPE CANCER IMMUNOTHERAPY HEAD & NECK CANCER MARKET BY COUNTRY, 2018 - 2024, USD MILLION
TABLE 25 EUROPE OTHER APPLICATION CANCER IMMUNOTHERAPY MARKET BY COUNTRY, 2014 - 2017, USD MILLION
TABLE 26 EUROPE OTHER APPLICATION CANCER IMMUNOTHERAPY MARKET BY COUNTRY, 2018 - 2024, USD MILLION
TABLE 27 EUROPE CANCER IMMUNOTHERAPY MARKET BY END USER, 2014 - 2017, USD MILLION
TABLE 28 EUROPE CANCER IMMUNOTHERAPY MARKET BY END USER, 2018 - 2024, USD MILLION
TABLE 29 EUROPE HOSPITALS CANCER IMMUNOTHERAPY MARKET BY COUNTRY, 2014 - 2017, USD MILLION
TABLE 30 EUROPE HOSPITALS CANCER IMMUNOTHERAPY MARKET BY COUNTRY, 2018 - 2024, USD MILLION
TABLE 31 EUROPE CLINICS CANCER IMMUNOTHERAPY MARKET BY COUNTRY, 2014 - 2017, USD MILLION
TABLE 32 EUROPE CLINICS CANCER IMMUNOTHERAPY MARKET BY COUNTRY, 2018 - 2024, USD MILLION
TABLE 33 EUROPE OTHER END USER CANCER IMMUNOTHERAPY MARKET BY COUNTRY, 2014 - 2017, USD MILLION
TABLE 34 EUROPE OTHER END USER CANCER IMMUNOTHERAPY MARKET BY COUNTRY, 2018 - 2024, USD MILLION
TABLE 35 EUROPE CANCER IMMUNOTHERAPY MARKET BY COUNTRY, 2014 - 2017, USD MILLION
TABLE 36 EUROPE CANCER IMMUNOTHERAPY MARKET BY COUNTRY, 2018 - 2024, USD MILLION
TABLE 37 GERMANY CANCER IMMUNOTHERAPY MARKET, 2014 - 2017, USD MILLION
TABLE 38 GERMANY CANCER IMMUNOTHERAPY MARKET, 2018 - 2024, USD MILLION
TABLE 39 GERMANY CANCER IMMUNOTHERAPY MARKET BY TECHNOLOGY, 2014 - 2017, USD MILLION
TABLE 40 GERMANY CANCER IMMUNOTHERAPY MARKET BY TECHNOLOGY, 2018 - 2024, USD MILLION
TABLE 41 GERMANY CANCER IMMUNOTHERAPY MARKET BY APPLICATION, 2014 - 2017, USD MILLION
TABLE 42 GERMANY CANCER IMMUNOTHERAPY MARKET BY APPLICATION, 2018 - 2024, USD MILLION
TABLE 43 GERMANY CANCER IMMUNOTHERAPY MARKET BY END USER, 2014 - 2017, USD MILLION
TABLE 44 GERMANY CANCER IMMUNOTHERAPY MARKET BY END USER, 2018 - 2024, USD MILLION
TABLE 45 UK CANCER IMMUNOTHERAPY MARKET, 2014 - 2017, USD MILLION
TABLE 46 UK CANCER IMMUNOTHERAPY MARKET, 2018 - 2024, USD MILLION
TABLE 47 UK CANCER IMMUNOTHERAPY MARKET BY TECHNOLOGY, 2014 - 2017, USD MILLION
TABLE 48 UK CANCER IMMUNOTHERAPY MARKET BY TECHNOLOGY, 2018 - 2024, USD MILLION
TABLE 49 UK CANCER IMMUNOTHERAPY MARKET BY APPLICATION, 2014 - 2017, USD MILLION
TABLE 50 UK CANCER IMMUNOTHERAPY MARKET BY APPLICATION, 2018 - 2024, USD MILLION
TABLE 51 UK CANCER IMMUNOTHERAPY MARKET BY END USER, 2014 - 2017, USD MILLION
TABLE 52 UK CANCER IMMUNOTHERAPY MARKET BY END USER, 2018 - 2024, USD MILLION
TABLE 53 FRANCE CANCER IMMUNOTHERAPY MARKET, 2014 - 2017, USD MILLION
TABLE 54 FRANCE CANCER IMMUNOTHERAPY MARKET, 2018 - 2024, USD MILLION
TABLE 55 FRANCE CANCER IMMUNOTHERAPY MARKET BY TECHNOLOGY, 2014 - 2017, USD MILLION
TABLE 56 FRANCE CANCER IMMUNOTHERAPY MARKET BY TECHNOLOGY, 2018 - 2024, USD MILLION
TABLE 57 FRANCE CANCER IMMUNOTHERAPY MARKET BY APPLICATION, 2014 - 2017, USD MILLION
TABLE 58 FRANCE CANCER IMMUNOTHERAPY MARKET BY APPLICATION, 2018 - 2024, USD MILLION
TABLE 59 FRANCE CANCER IMMUNOTHERAPY MARKET BY END USER, 2014 - 2017, USD MILLION
TABLE 60 FRANCE CANCER IMMUNOTHERAPY MARKET BY END USER, 2018 - 2024, USD MILLION
TABLE 61 RUSSIA CANCER IMMUNOTHERAPY MARKET, 2014 - 2017, USD MILLION
TABLE 62 RUSSIA CANCER IMMUNOTHERAPY MARKET, 2018 - 2024, USD MILLION
TABLE 63 RUSSIA CANCER IMMUNOTHERAPY MARKET BY TECHNOLOGY, 2014 - 2017, USD MILLION
TABLE 64 RUSSIA CANCER IMMUNOTHERAPY MARKET BY TECHNOLOGY, 2018 - 2024, USD MILLION
TABLE 65 RUSSIA CANCER IMMUNOTHERAPY MARKET BY APPLICATION, 2014 - 2017, USD MILLION
TABLE 66 RUSSIA CANCER IMMUNOTHERAPY MARKET BY APPLICATION, 2018 - 2024, USD MILLION
TABLE 67 RUSSIA CANCER IMMUNOTHERAPY MARKET BY END USER, 2014 - 2017, USD MILLION
TABLE 68 RUSSIA CANCER IMMUNOTHERAPY MARKET BY END USER, 2018 - 2024, USD MILLION
TABLE 69 SPAIN CANCER IMMUNOTHERAPY MARKET, 2014 - 2017, USD MILLION
TABLE 70 SPAIN CANCER IMMUNOTHERAPY MARKET, 2018 - 2024, USD MILLION
TABLE 71 SPAIN CANCER IMMUNOTHERAPY MARKET BY TECHNOLOGY, 2014 - 2017, USD MILLION
TABLE 72 SPAIN CANCER IMMUNOTHERAPY MARKET BY TECHNOLOGY, 2018 - 2024, USD MILLION
TABLE 73 SPAIN CANCER IMMUNOTHERAPY MARKET BY APPLICATION, 2014 - 2017, USD MILLION
TABLE 74 SPAIN CANCER IMMUNOTHERAPY MARKET BY APPLICATION, 2018 - 2024, USD MILLION
TABLE 75 SPAIN CANCER IMMUNOTHERAPY MARKET BY END USER, 2014 - 2017, USD MILLION
TABLE 76 SPAIN CANCER IMMUNOTHERAPY MARKET BY END USER, 2018 - 2024, USD MILLION
TABLE 77 ITALY CANCER IMMUNOTHERAPY MARKET, 2014 - 2017, USD MILLION
TABLE 78 ITALY CANCER IMMUNOTHERAPY MARKET, 2018 - 2024, USD MILLION
TABLE 79 ITALY CANCER IMMUNOTHERAPY MARKET BY TECHNOLOGY, 2014 - 2017, USD MILLION
TABLE 80 ITALY CANCER IMMUNOTHERAPY MARKET BY TECHNOLOGY, 2018 - 2024, USD MILLION
TABLE 81 ITALY CANCER IMMUNOTHERAPY MARKET BY APPLICATION, 2014 - 2017, USD MILLION
TABLE 82 ITALY CANCER IMMUNOTHERAPY MARKET BY APPLICATION, 2018 - 2024, USD MILLION
TABLE 83 ITALY CANCER IMMUNOTHERAPY MARKET BY END USER, 2014 - 2017, USD MILLION
TABLE 84 ITALY CANCER IMMUNOTHERAPY MARKET BY END USER, 2018 - 2024, USD MILLION
TABLE 85 REST OF EUROPE CANCER IMMUNOTHERAPY MARKET, 2014 - 2017, USD MILLION
TABLE 86 REST OF EUROPE CANCER IMMUNOTHERAPY MARKET, 2018 - 2024, USD MILLION
TABLE 87 REST OF EUROPE CANCER IMMUNOTHERAPY MARKET BY TECHNOLOGY, 2014 - 2017, USD MILLION
TABLE 88 REST OF EUROPE CANCER IMMUNOTHERAPY MARKET BY TECHNOLOGY, 2018 - 2024, USD MILLION
TABLE 89 REST OF EUROPE CANCER IMMUNOTHERAPY MARKET BY APPLICATION, 2014 - 2017, USD MILLION
TABLE 90 REST OF EUROPE CANCER IMMUNOTHERAPY MARKET BY APPLICATION, 2018 - 2024, USD MILLION
TABLE 91 REST OF EUROPE CANCER IMMUNOTHERAPY MARKET BY END USER, 2014 - 2017, USD MILLION
TABLE 92 REST OF EUROPE CANCER IMMUNOTHERAPY MARKET BY END USER, 2018 - 2024, USD MILLION
TABLE 93 KEY INFORMATION-AMGEN INC.
TABLE 94 KEY INFORMATION-MERCK & COMPANY INC.
TABLE 95 KEY INFORMATION- PFIZER INC.
TABLE 96 KEY INFORMATION- IMMUNOMEDICS INC.
TABLE 97 KEY INFORMATION- ASTRAZENECA PLC.
TABLE 98 KEY INFORMATION- F. HOFFMANN-LA ROCHE LTD.
TABLE 99 KEY INFORMATION – ELI LILLY AND COMPANY
TABLE 100 KEY INFORMATION – NOVARTIS AG
TABLE 101 KEY INFORMATION - BRISTOL-MYERS SQUIBB COMPANY
TABLE 102 KEY INFORMATION – BAYER AG
